Literature DB >> 9075481

Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma.

C A Brennan1, J Yamaguchi, A S Vallari, R K Hickman, S G Devare.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9075481     DOI： 10.1089/aid.1997.13.401

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  7 in total

1.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

2.  V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.

Authors:  J C Plantier; F Damond; S Souquières; F Brun-Vézinet; F Simon; F Barin
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

4.  Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.

Authors:  A S Vallari; R K Hickman; J R Hackett; C A Brennan; V A Varitek; S G Devare
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 5.  Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

6.  High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences.

Authors:  Junko S Takeuchi; Benjamin Perche; Julie Migraine; Séverine Mercier-Delarue; Diane Ponscarme; François Simon; François Clavel; Béatrice Labrosse
Journal:  Retrovirology       Date:  2013-05-06       Impact factor: 4.602

7.  Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso.

Authors:  Peter N Fonjungo; Marcia L Kalish; Amanda Schaefer; Mark Rayfield; Jennifer Mika; Laura E Rose; Orville Heslop; Robert Soudré; Danuta Pieniazek
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.